1. Home
  2. THRY vs ACHV Comparison

THRY vs ACHV Comparison

Compare THRY & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

HOLD

Current Price

$3.72

Market Cap

170.3M

Sector

Industrials

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$5.12

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRY
ACHV
Founded
2012
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.3M
172.0M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
THRY
ACHV
Price
$3.72
$5.12
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$9.33
$14.67
AVG Volume (30 Days)
917.2K
1.4M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
100.50
N/A
EPS
0.10
N/A
Revenue
$785,015,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$38.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.91
$2.00
52 Week High
$14.28
$6.15

Technical Indicators

Market Signals
Indicator
THRY
ACHV
Relative Strength Index (RSI) 51.35 53.31
Support Level $3.46 $4.04
Resistance Level $4.17 $5.30
Average True Range (ATR) 0.29 0.38
MACD -0.01 -0.02
Stochastic Oscillator 43.32 56.82

Price Performance

Historical Comparison
THRY
ACHV

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: